Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Dennis W. Grauer, MS, PhD
Authored Items
Evaluation of Inpatient Oral Chemotherapy: An Academic Medical Center Experience
Vincent J. Cascone, PharmD, BCOP
,
Kane M. Hosmer, PharmD, BCOP
,
Zahra Mahmoudjafari, PharmD, BCOP
,
David W. Henry, MS, RPh, BCOP, FASHP
,
Dennis W. Grauer, MS, PhD
JHOP - December 2020 Vol 10, No 6
in
Original Research
,
Chemotherapy
Risk Factors for Subtherapeutic Tacrolimus Levels After Conversion from Intravenous to Oral Dosing Posttransplant in Adults
Kelsey Konrardy, PharmD
,
Kane M. Hosmer, PharmD, BCOP
,
Michelle Rockey, PharmD, BCOP, FHOPA
,
Zahra Mahmoudjafari, PharmD, BCOP
,
Dennis W. Grauer, MS, PhD
,
David W. Henry, MS, RPh, BCOP, FASHP
,
Leyla Shune, MD
,
Joseph McGuirk, DO
JHOP - June 2020 Vol 10, No 3
in
Original Research
,
Transplant
The Impact of Angiotensin II Receptor Blocker Use in Patients with Prostate Cancer
Lisa Cerutti, PharmD
,
Jacob K. Kettle, PharmD, BCOP
,
Dennis W. Grauer, MS, PhD
JHOP - December 2013 VOL 3, NO 4
in
Original Research
Last modified: January 15, 2021